EssilorLuxottica: the optics specialist recorded a very sharp decline in its profits in 2020, well above the decline in its revenues. A final dividend of EUR 1.08 per share will be proposed (an interim dividend of EUR 1.15 has already been paid). Management has not released any guidance, but expects to "achieve a performance comparable to the pre-pandemic level".

Antitrust regulators are considering a record fine for Alibaba, higher than the $975 million Qualcomm Inc. paid in 2015 for anti-competitive practices, according to people with knowledge of the case cited by The Wall Street Journal.

The Boeing company has signed an agreement with 777 Partners for a firm order for 24 737-8s and 60 other aircraft as options.

Renesas CEO warns that the semiconductor shortage could continue into the second half of the year.

Burberry expects to outperform consensus.

Novavax announced that studies have shown its experimental vaccine to be 96.4% effective against the original Covid-19 strain. It is also 86% effective against the English variant. But there is lower efficacy against the South African variant.

Deutsche Bank expects revenues to be slightly below 2020 this year.

Europe approves Johnson & Johnson's Covid-19 vaccine.

Xiaomi surges after announcing a 10BHKD share buyback program.

Baidu hopes to raise up to $3.6 billion via a listing in Hong Kong.

AstraZeneca's vaccine shipments to Europe will be much lower than expected in the second quarter.

Payment company Flylwire is preparing to go public.

Verizon launches giant $25 billion bond issue in nine tranches.

Japan Post takes an 8.3% stake in Rakuten.

Coupang flares up for its IPO.

Noxxon's DSMB clears final Phase I/II patients with NOX-A12 in brain cancer.

Lonza expands its manufacturing agreement with Altimmune against Covid-19.

VTC company Grab is discussing a merger with a SPAC (Altimeter Growth Corp. or Altimeter Growth Corp. 2) for a record amount.

Wisekey enters the capital of FOSSA Systems.